# Safety and Efficacy of Nalmefene in Patients With Alcohol Dependence

> **NCT00811941** · PHASE3 · COMPLETED · sponsor: **H. Lundbeck A/S** · enrollment: 665 (actual)

## Conditions studied

- Alcohol Dependence

## Interventions

- **DRUG:** Placebo
- **DRUG:** Nalmefene

## Key facts

- **NCT ID:** NCT00811941
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 665 (ACTUAL)
- **Last updated:** 2013-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00811941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00811941, "Safety and Efficacy of Nalmefene in Patients With Alcohol Dependence". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00811941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*